1. Ganijee M, Sahgal GR, Latif B, Ahmad MT. Comment on: Evaluation of the influence of sildenafil on the safety, tolerability, pharmacokinetics, and pharmacodynamics of vericiguat in healthy adults. Clin Pharmacokinet. 2023. https://doi.org/10.1007/s40262-023-01303-w.
2. Boettcher M, Nowotny B, Krausche R, Becker C. Evaluation of the influence of sildenafil on the safety, tolerability, pharmacokinetics, and pharmacodynamics of vericiguat in healthy adults. Clin Pharmacokinet. 2023;62(2):321–33.
3. European Medicines Agency. Viagra summary of product characteristics. 2023. https://www.ema.europa.eu/en/documents/product-information/viagra-epar-product-information_en.pdf. Accessed 31 July 2023.
4. European Medicines Agency. Revatio summary of product characteristics. 2023. https://www.ema.europa.eu/en/documents/product-information/revatio-epar-product-information_en.pdf. Accessed 31 July 2023.
5. European Medicines Agency. Adempas summary of product characteristics. 2022. https://www.ema.europa.eu/en/documents/product-information/adempas-epar-product-information_en.pdf. Accessed 31 July 2023.